The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update.
The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update.
复制标题
烟酰胺N-甲基转移酶是预测泌尿外科癌症的肿瘤学结局的潜在生物标志物:更新。
DOI:
10.3390/biom11081214
复制
发表时间:
2021-08-16
期刊:
影响因子:
5.5
通讯作者:
Emanuelli M
中科院分区:
文献类型:
--
作者:
Campagna R;Pozzi V;Spinelli G;Sartini D;Milanese G;Galosi AB;Emanuelli M
Nicotinamide N-methyltransferase (NNMT) catalyzes the N-methylation reaction of nicotinamide, using S-adenosyl-L-methionine as the methyl donor. Enzyme overexpression has been described in many non-neoplastic diseases, as well as in a wide range of solid malignancies. This review aims to report and discuss evidence available in scientific literature, dealing with NNMT expression and the potential involvement in main urologic neoplasms, namely, renal, bladder and prostate cancers. Data illustrated in the cited studies clearly demonstrated NNMT upregulation (pathological vs. normal tissue) in association with these aforementioned tumors. In addition to this, enzyme levels were also found to correlate with key prognostic parameters and patient survival. Interestingly, NNMT overexpression also emerged in peripheral body fluids, such as blood and urine, thus leading to candidate the enzyme as promising biomarker for the early and non-invasive detection of these cancers. Examined results undoubtedly showed NNMT as having the capacity to promote cell proliferation, migration and invasiveness, as well as its potential participation in fundamental events highlighting cancer progression, metastasis and resistance to chemo- and radiotherapy. In the light of this evidence, it is reasonable to attribute to NNMT a promising role as a potential biomarker for the diagnosis and prognosis of urologic neoplasms, as well as a molecular target for effective anti-cancer treatment.
登录
查看更多内容
DOI:
10.1016/j.omtn.2018.03.011
发表时间:
2018-06-01
期刊:
Molecular therapy. Nucleic acids
影响因子:
--
作者:
Bach DH;Kim D;Bae SY;Kim WK;Hong JY;Lee HJ;Rajasekaran N;Kwon S;Fan Y;Luu TT;Shin YK;Lee J;Lee SK
通讯作者:
Lee SK
影响因子:
7.3
作者:
Chen, Dongxing;Li, Linjie;Huang, Rong
通讯作者:
Huang, Rong
影响因子:
4.3
作者:
Campagna, Roberto;Salvolini, Eleonora;Emanuelli, Monica
通讯作者:
Emanuelli, Monica
影响因子:
4.2
作者:
Hah, Young-Sool;Cho, Hee Young;Yoon, Tae-Jin
通讯作者:
Yoon, Tae-Jin
影响因子:
4.6
作者:
Cui, Yanyan;Yang, Dawei;Guan, Fangxia
通讯作者:
Guan, Fangxia